carbon monoxide has been researched along with Acquired Immune Deficiency Syndrome in 5 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, the polymerase chain reaction (PCR) was used to determine if the reductions in transfer factor for lung carbon monoxide (TLCO) were due to the presence of HIV-1 or cytomegalovirus (CMV)." | 7.68 | Effect of HIV-1 and cytomegalovirus in bronchoalveolar lavage cells on the transfer factor for lung carbon monoxide in AIDS patients. ( Clarke, JR; Donegan, K; Fleming, J; Mitchell, DM; Moss, FM; Nieman, R; Williamson, JD, 1991) |
| " In this study, the polymerase chain reaction (PCR) was used to determine if the reductions in transfer factor for lung carbon monoxide (TLCO) were due to the presence of HIV-1 or cytomegalovirus (CMV)." | 3.68 | Effect of HIV-1 and cytomegalovirus in bronchoalveolar lavage cells on the transfer factor for lung carbon monoxide in AIDS patients. ( Clarke, JR; Donegan, K; Fleming, J; Mitchell, DM; Moss, FM; Nieman, R; Williamson, JD, 1991) |
| "A diffuse nonspecific interstitial pneumonitis was present in lungs of immunodeficient mice, and flow cytometry indicated that both lymphocytes and macrophages were activated." | 1.30 | Pulmonary mechanical and immunologic dysfunction in a murine model of AIDS. ( Cohen, DA; Gillespie, MN; Hartsfield, CL; Lai, YL; Lipke, D, 1997) |
| "Eighty four individuals with AIDS, who had regular pulmonary function tests before the diagnosis of AIDS was made, were identified from a cohort of patients with HIV-I infection." | 1.29 | Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS. ( Coker, RJ; Fleming, J; Harris, JR; Mitchell, DM; Nieman, RB, 1993) |
| "Patients with the AIDS related complex, non-pulmonary Kaposi sarcoma, and non-pulmonary non-Kaposi sarcoma AIDS (that is, opportunist infections affecting other organs) had lower mean values for TLCO (77%, 70%, and 70% of predicted respectively)." | 1.27 | Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. ( Forster, SM; Harris, JR; Mitchell, DM; Pinching, AJ; Roussak, C; Shaw, RJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nieman, RB | 1 |
| Fleming, J | 2 |
| Coker, RJ | 1 |
| Harris, JR | 2 |
| Mitchell, DM | 3 |
| Hartsfield, CL | 1 |
| Lipke, D | 1 |
| Lai, YL | 1 |
| Cohen, DA | 1 |
| Gillespie, MN | 1 |
| Ireland-Gill, A | 1 |
| Espina, BM | 1 |
| Akil, B | 1 |
| Gill, PS | 1 |
| Clarke, JR | 1 |
| Donegan, K | 1 |
| Moss, FM | 1 |
| Nieman, R | 1 |
| Williamson, JD | 1 |
| Shaw, RJ | 1 |
| Roussak, C | 1 |
| Forster, SM | 1 |
| Pinching, AJ | 1 |
5 other studies available for carbon monoxide and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Carbon Monoxide; Cohort Studies; Female; HIV Infections; | 1993 |
Pulmonary mechanical and immunologic dysfunction in a murine model of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Carbon Monoxide; Collagen; Cytokines; Disease Models, A | 1997 |
Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1992 |
Effect of HIV-1 and cytomegalovirus in bronchoalveolar lavage cells on the transfer factor for lung carbon monoxide in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Bronchoalveolar Lavage Fluid; Carbon Monoxide; Cytomegalovirus; | 1991 |
Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis.
Topics: Acquired Immunodeficiency Syndrome; Carbon Monoxide; HIV Seropositivity; Humans; Lung; Male; Pneumon | 1988 |